Document Detail


Treatment for pulmonary hypertension including lung transplantation.
MedLine Citation:
PMID:  21850579     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Pulmonary hypertension (PH) is a progressive disease characterized by sustained elevation in pulmonary arterial pressure and increased pulmonary vascular resistance, leading to right-sided ventricular failure. The untreated median survival period is 2-3 years from the time of diagnosis, with the cause of death usually being right-sided ventricular failure. However, outcomes have dramatically changed in recent years because of great advances in medical management of PH, including early diagnosis and new drugs such as prostaglandins, endothelin receptor antagonists, and phosphodiesterase type 5 inhibitors. Long-term continuous intravenous prostacyclin therapy has shown excellent results in patients with PH. More recently, a molecular-targeted agent, imatinib mesylate, that acts by specifically inhibiting a certain enzyme that is characteristic of a particular cancer cell, rather than nonspecifically inhibiting and killing all rapidly dividing cells, has also been shown to have a potential role in the treatment of PH. This drug has been shown to reduce both pulmonary arterial smooth muscle cell hypertrophy and hyperplasia in a variety of disease processes. We summarize here recent topics regarding PH and advances in treatments for PH, particularly pulmonary arterial hypertension, including lung transplantation.
Authors:
Kengo F Kusano
Related Documents :
3621539 - Asynchronous primary valve failure in patients with porcine bioprosthetic aortic and mi...
10196619 - Ureter and bladder replacement following radical cystectomy.
15818369 - Repair of tetralogy of fallot with absent pulmonary valve using a new approach.
4028369 - Replacement of obstructed right ventricular-pulmonary arterial valved conduits with non...
12928649 - Use of bovine jugular vein to reconstruct the right ventricular outflow tract: early re...
22257549 - Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case ...
6666219 - The mass transport of the arterial wall: effect of mechanical stresses and vasoactive a...
11442999 - Role of vascular smooth muscle in the development of high altitude pulmonary hypertensi...
18326129 - The incidence and risk of central venous catheter malpositioning: a prospective cohort ...
Publication Detail:
Type:  Journal Article     Date:  2011-08-18
Journal Detail:
Title:  General thoracic and cardiovascular surgery     Volume:  59     ISSN:  1863-6713     ISO Abbreviation:  Gen Thorac Cardiovasc Surg     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-08-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101303952     Medline TA:  Gen Thorac Cardiovasc Surg     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  538-46     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan, kusanokengo@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular oncology of lung cancer.
Next Document:  High-velocity penetrating thoracic trauma with suspected cardiac involvement in a combat support hos...